Targeting the BH3-interacting domain death agonist to develop mechanistically unique antidepressants
about
Cell atrophy and loss in depression: reversal by antidepressant treatmentDiscovery and validation of blood biomarkers for suicidalityAcute D-serine treatment produces antidepressant-like effects in rodentsPurinergic signaling and energy homeostasis in psychiatric disordersMitochondria and the central nervous system: searching for a pathophysiological basis of psychiatric disorders.Phosphodiesterase-1b deletion confers depression-like behavioral resistance separate from stress-related effects in mice.
P2860
Targeting the BH3-interacting domain death agonist to develop mechanistically unique antidepressants
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Targeting the BH3-interacting ...... tically unique antidepressants
@ast
Targeting the BH3-interacting ...... tically unique antidepressants
@en
type
label
Targeting the BH3-interacting ...... tically unique antidepressants
@ast
Targeting the BH3-interacting ...... tically unique antidepressants
@en
prefLabel
Targeting the BH3-interacting ...... tically unique antidepressants
@ast
Targeting the BH3-interacting ...... tically unique antidepressants
@en
P2093
P2860
P356
P1433
P1476
Targeting the BH3-interacting ...... tically unique antidepressants
@en
P2093
D R Austin
I D Henter
M Pellecchia
O Malkesman
P2860
P2888
P304
P356
10.1038/MP.2011.77
P407
P577
2011-07-05T00:00:00Z